J&J Raises Outlook to Target $100B Revenue, Lifts Dow Sentiment
Johnson & Johnson raised its 2026 financial targets, projecting 6.5% sales growth and adjusted EPS growth of 7.3%, topping $100 billion in revenue. Despite STELARA biosimilar headwinds, management an…